Extracorporeal membrane oxygenation in a patient with newly diagnosed acute myeloblastic leukaemia presenting with severe respiratory failure
- 12 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Artificial Organs
- Vol. 24 (3), 387-391
- https://doi.org/10.1007/s10047-020-01225-5
Abstract
Veno-venous extracorporeal membrane oxygenation (ECMO) is typically instituted in severe respiratory failure, defined by Lung Injury Score, and caused either by pulmonary or extra-pulmonary reversible disease processes. These processes will have led to acute worsening of oxygenation and/or respiratory acidosis together with an inability to provide safe, lung protective, mechanical ventilation. Patients with underlying chronic immunosuppression or haematological malignancies treated with ECMO for severe respiratory failure have poor short- and long-term functional and survival outcomes. Consequently, in many centres, a diagnosis of haematological malignancy is considered a contraindication to provision of ECMO support for severe respiratory failure. We present a case of a 51-year-old female who attended her local hospital with symptoms suggestive of community-acquired pneumonia. Within a few days, there was progression to severe respiratory failure, initially managed with invasive mechanical ventilation but rapidly deteriorating respiratory failure triggered referral for ECMO support. Initial investigations on ECMO demonstrated features of acute myeloblastic leukaemia with a superimposed community-acquired pneumonia. This was successfully managed with supportive treatment alongside mechanical respiratory therapy and targeted chemotherapy, achieving complete remission and full functional recovery.Keywords
This publication has 13 references indexed in Scilit:
- ECMO without anticoagulation in patients with disease‐related severe thrombocytopenia: Feasible but futile?Artificial Organs, 2019
- Salvage extracorporeal membrane oxygenation in induction-associated acute respiratory distress syndrome in acute leukemia patients: A case seriesThe International Journal of Artificial Organs, 2018
- Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre ExperienceOncology Research and Treatment, 2018
- Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemiaJournal of Oncology Pharmacy Practice, 2018
- Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane OxygenationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Extracorporeal membrane oxygenation as a rescue therapy for acute respiratory failure during chemotherapy in a patient with acute myeloid leukemiaJournal of Thoracic Disease, 2017
- Oxygenator failure in acute myeloid leukaemia. A case reportPerfusion, 2016
- Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignanciesThe Korean Journal of Internal Medicine, 2015
- Respiratory events at the earliest phase of acute myeloid leukemiaLeukemia & Lymphoma, 2014
- Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failureCritical Care, 2014